Hospital-based Prospective Registration of Acute Ischemic Stroke and Transient Ischemic Attack in Japan

Journal of Stroke and Cerebrovascular Diseases

Volumn 13, Issue 1, 2004, Pages 1-11

  Kimura, Kazumi ^a   Kazui, Seiji ^a   Minematsu, Kazuo ^a   Yamaguchi, Takenori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Acute; Brain infarction; Prospective study; Statistics; Stroke; Stroke management; Transient ischemic attack

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION; COMORBIDITY; DIABETES MELLITUS; DISEASE DURATION; EMBOLISM; FEMALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; REGISTER; RISK FACTOR; STROKE; SYMPTOMATOLOGY; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 1842584363     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2003.11.025     Document Type: Article

References (39)

1. Sarti C, Rastenyte DR, Cepaitis Z, et al. International trends in mortality from stroke, 1968 to 1994. Stroke 2000;31:1588-1601.
2. Morikawa Y, Nakagawa H, Naruse Y, et al. Trends in stroke incidence and acute case fatality in a Japanese rural area. The Oyabe study. Stroke 2000;31:1583-1587.
3. Kodama K. Stroke trends in Japan. Ann Epidemiol 1993;3:524-528.
4. Ministry of Health, Labour and Welfare. Social and economic changes surrounding individuals. Annual Report on Health, Labour and Welfare 2000-2001. Health, Labour and Welfare Administration for Providing Life-Long Support to Self-Sufficiency of the People. Tokyo, Japan, Gyosei Corporation, 2002, 136-150.
5. National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Classification of cerebrovascular diseases III. Stroke 1990;21:637-675.
6. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
7. Rothrock JF, Lyden PD, Brody ML, et al. An analysis of ischemic stroke in an urban southern California population. The University of California, San Diego, Stroke data bank. Arch Intern Med 1993;153:619-624.
8. Kay R, Woo J, Kreel L, et al. Stroke subtypes among Chinese living in Hong Kong: The Shatin stroke registry. Neurology 1992;42:985-987.
9. Misbach J, Ali W. Stroke in Indonesia: A first large prospective hospital-based study of acute stroke in 28 hospitals in Indonesia. J Clin Neurosci 2001;8:245-249.
10. Yip PK, Jeng JS, Lee TK, et al. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 1997;28:2507-2512.
11. Bogousslavasky J, Melle GV, Rgli F. The Lausanne stroke registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
12. Yatsu FM, Becker C, McLeroy KR, et al. Community hospital based stroke programs: North Carolina, Oregon, and New York I: Goals, objectives and data collection procedures. Stroke 1986;17:276-284.
13. Brutto OHD, Mosquera A, Sanchez X, et al. Stroke subtype Hispanics living from Guayaquil, Ecuador. Results from the Luis Vernaza hospital stroke registry. Stroke 1993;24:1833-1836.
14. Lee BI, Nam HS, Heo JH, et al and the Yonei stroke team. Yonsei stroke registry. Cerebrovasc Dis 2001;12:145-151.
15. Foulkes MA, Wolf PA, Price TR, et al. The stroke data bank: Design, methods, and baseline characteristics. Stroke 1988;19:547-554.
16. Tanizaki Y, Kiyohara Y, Kato I, et al. Incidence and risk factors for subtypes of cerebral infarction in a general population. The Hisayama study. Stroke 2000;31:2616-2622.
17. Petty GW, Brown Jr RD, Whisnant JP, et al. Ischemic stroke subtype. A population-based study of incidence and risk factors. Stroke 1999;30:2513-2516.
18. Kolominisky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtype: A population-based study. Stroke 2001;31:2735-2740.
19. Friday G, Lai SM, Alter M, et al. Stroke in the Lehigh Valley: Racial/ethnic differences. Neurology 1989;39:1165-1168.
20. Wester P, Radberg J, Lundgren B, et al for the Seek-Medical-Attention-in-Time Study Group. Factor associated with delayed admission to hospital and in hospital delays in acute stroke and TIA. A prospective, multicenter study. Stroke 1999;30:40-48.
21. Indredavik B, Bakke F, Slordahl SA, et al. Stroke unit treatment improve long-term quality of life. A randomized controlled trial. Stroke 1998;29:895-899.
22. Ronning OM, Guldvog B. Stroke unit versus general ward, I: Twelve-and eighteen-month survival. A randomized controlled trial. Stroke 1998;29:58-62.
23. Ronning OM, Guldvog B. Stroke unit versus general ward, II: Neurological deficits and activities of daily living. A Quasi-randomized controlled trial. Stroke 1998;29:586-590.
24. Adams HP, Davis PH, Leira EC, et al. Baseline NIH stroke scale score strongly predicts outcome after stroke. A report of the trial of Org 10172 in acute stroke treatment (TOAST). Neurology 1999;53:126-131.
25. Minematsu K, Yamaguchi K, Omae T. Spectacular shrinking deficit: Rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992;42:157-162.
26. National Institute of Neurological Disorders and Stroke rt-PA stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
27. Hacke W, Kaste M, Fieschi C, et al for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
28. Barber PA, Zhang J, Demchuk AM, et al. Why are stroke patients excluded from TPA therapy? An analysis of patients' eligibility. Neurology 2001;56:1015-1020.
29. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
30. Bornstein NM, Aronovich BD, Karepov VG, et al. The Tel Aviv stroke registry 3600 consecutive patients. Stroke 1996;27:1770-1773.
31. Frey JL, Jahnke HK, Bulfinch EW. Differences in stroke between White, Hispanic and native American patients. The Barrow Neurological Institute stroke database. Stroke 1998;29:29-33.
32. Feigin VL, Wiebers DO, Nikitin YP, et al. Risk factors for ischemic stroke in a Russian community. A population-based case-control study. Stroke 1999;29:34-39.
33. Smadja D, Cabre P, May F, et al and the ERMANCIA study group. ERMANCIA: Epidemiology of stroke in Martinique, French West Indies. Stroke 2001;32:2741-2747.
34. Sacco RL, Benjamin CEJ, Broderick JP, et al. Risk factors. Stroke 1997;28:1507-1517.
35. Summary of the National Cholesterol Education Program (NCEP) Adult Treatment Panel II report. JAMA 1993;269:3015-3023.
36. Bonita R, Boad JB, Beaglehole R. Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91. Lancet 1993;342:1470-1473.
37. Stegmayr B, Asplund K, Wester PO. Trends in incidence, case-fatality rate, and severity of stroke in Northern Sweden, 1985-1991. Stroke 1994;25:1738-1745.
38. Hong Y, Bots ML, Pan X, et al. Stroke incidence and mortality in rural and urban Shanghai from 1984 through 1991. Findings from a community-based registry. Stroke 1994;25:1165-1169.
39. Korv J, Roose M, Kaasik AE. Changed incidence and case-fatality rates of first-ever stroke between 1970 and 1993 in Tartu, Estonia. Stroke 1996;27:199-203.